Skip to content
Governance Register

← US public companies

Portola Pharmaceuticals INC

SEC CIK 1269021 · PTLA · last insider filing 2020-07-06

Directors (from insider filings)

NameCapacity as filedFilings
Bird Jeffrey W Director filed 2013 - 2020
Fenton Dennis M Director filed 2015 - 2020
Renton Hollings Director filed 2013 - 2020
Love TED W Director filed 2019 - 2020
Stump David C Director filed 2015 - 2020
Wolff Henry Ward Director filed 2013 - 2020
Brege Laura Director filed 2015 - 2020
Johnson John H Director filed 2014 - 2020
Garland J. Scott Director · President and CEO filed 2018 - 2020
Homcy Charles J Director filed 2013 - 2019
Lis William Director · Chief Executive Officer filed 2013 - 2018
Galakatos Nicholas Director filed 2013 - 2014
Califf Robert Director filed 2013 - 2014
Bienaime Jean Jacques Director filed 2013 - 2014
Topper James N Director filed 2013 - 2013
Hirsch Russell C Director filed 2013 - 2013
Champsi Farah Director filed 2013 - 2013
George Jean Director filed 2013 - 2013
Phillips Peggy V Director filed 2013 - 2013

Officers (from insider filings)

NameTitle as filedFilings
Moriarty John B EVP, General Counsel filed 2018 - 2020
Dier Mardi Senior VP and CFO filed 2013 - 2020
Patni Rajiv EVP, CMO filed 2020 - 2020
Brame Glenn P SVP, Technical Operations filed 2018 - 2020
Meyer Ernie EVP and CHRO filed 2018 - 2020
Koenig Sheldon L. EVP, Chief Commercial Officer filed 2019 - 2020
Curnutte John T Interim Co-President & EVP R&D filed 2013 - 2019
Fu Tao EVP, CBO filed 2015 - 2018
Lawrence John H III SVP, Chief Medical Officer filed 2017 - 2018
Kitt Michael Senior VP and CMO filed 2013 - 2013

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.